Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

Explore Lineage Cell Therapeutics' Q1 2025 insights, including OpRegen progress, a manufacturing milestone, key clinical data, and a strong financial outlook.

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

North Carolina Gov. Josh Stein announced that Genentech, a biotechnology company, will build a new manufacturing plant in Wake County, creating 420 jobs.

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. | The announcement follows a five-year, $50 billion ...

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...